(Q24813937)

5 July 2017

title

Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer (English)

1 reference

5 July 2017

0 references

cervix uterine cancer

1 reference

Carlos Lopez-Graniel

1

1 reference

5 July 2017

Rigoberto Dolores

2

1 reference

5 July 2017

Lucely Cetina

3

1 reference

5 July 2017

Aaron Gonzalez

4

1 reference

5 July 2017

David Cantu

5

1 reference

5 July 2017

Jose Chanona

6

1 reference

5 July 2017

Jesus Uribe

7

1 reference

5 July 2017

Myrna Candelaria

8

1 reference

5 July 2017

Rocio Brom

9

1 reference

5 July 2017

Jaime de la Garza

10

1 reference

5 July 2017

Alfonso Duenas-Gonzalez

11

1 reference

5 July 2017

language of work or name

English

0 references

publication date

19 September 2005

1 reference

5 July 2017

1 reference

5 July 2017

volume

5

1 reference

5 July 2017

issue

1

0 references

page(s)

118

1 reference

The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer.

5 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1260014

Modern management of locally advanced cervical carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1260014

Uterine cervical carcinoma after therapy: CT and MR imaging findings

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1260014

Role of systemic chemotherapy in metastatic cervical cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1260014

Guidelines for the treatment of recurrent and metastatic cervical cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1260014

Recurrent cervical cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1260014

Estimating the world cancer burden: Globocan 2000.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1260014

CT evaluation of cervical cancer: spectrum of disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1260014

The role of intraoperative radiation therapy (IORT) in the treatment of locally advanced gynecologic malignancies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1260014

Exenterative pelvic surgery

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1260014

Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1260014

Surgical management of advanced and recurrent cervical cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1260014

Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1260014

Aborted exenterative procedures in recurrent cervical cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1260014

Exenterative operations: Experience with 198 patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1260014

Nonresectable recurrent pelvic neoplasm. Outcome in patients explored for pelvic exenteration

30 May 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-5-118

A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-5-118

Induction chemotherapy with gemcitabine and oxaliplatin for locally advanced cervical carcinoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-5-118

Laterally extended endopelvic resection: surgical treatment of infrailiac pelvic wall recurrences of gynecologic malignancies

21 January 2018

1 reference

12 December 2020

Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix

1 reference

12 December 2020

Radical surgical resection and high-dose intraoperative radiation therapy (HDR-IORT) in patients with recurrent gynecologic cancers

1 reference

12 December 2020

Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy

1 reference

12 December 2020

Explorative laparoscopy prior to exenterative surgery

1 reference

12 December 2020

A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation

1 reference

12 December 2020

Laterally extended endopelvic resection. Novel surgical treatment of locally recurrent cervical carcinoma involving the pelvic side wall

1 reference

12 December 2020

Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study

1 reference

12 December 2020

Critical points of failure in the therapy of cancer of the cervix: A reappraisal

1 reference

12 December 2020

Pelvic exenteration: analysis of 296 patients

1 reference

12 December 2020

Recurrent carcinoma of the cervix: CT diagnosis

1 reference

12 December 2020

Palliative exenteration--what, when, and why?

1 reference

12 December 2020

Uterine cervical carcinoma: comparison of CT and MR findings

1 reference

12 December 2020

Pelvic exenteration in the elderly patient

1 reference

12 December 2020

The combined operative and radiotherapeutic treatment (CORT) of recurrent tumors infiltrating the pelvic wall: First experience with 18 patients

1 reference

12 December 2020

The role of MR imaging in determining surgical eligibility for pelvic exenteration

1 reference

12 December 2020

[Pelvic exenteration for cancer of the uterine cervix (prognostic factors)]

1 reference

12 December 2020

Preoperative evaluation of tumor extension in patients with recurrent cervical cancer

1 reference

12 December 2020

Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging

1 reference

12 December 2020

Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design

1 reference

12 December 2020

Improvements in pelvic exenteration: factors responsible for reducing morbidity and mortality

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-5-118

1 reference

Dimensions Publication ID

5 July 2017

0 references

1 reference

5 July 2017

1 reference